These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1528 related articles for article (PubMed ID: 30213667)

  • 1. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues.
    Parola M; Pinzani M
    Mol Aspects Med; 2019 Feb; 65():37-55. PubMed ID: 30213667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis.
    Foglia B; Cannito S; Bocca C; Parola M; Novo E
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic myofibroblasts and fibrogenic progression of chronic liver diseases.
    Novo E; Cannito S; Morello E; Paternostro C; Bocca C; Miglietta A; Parola M
    Histol Histopathol; 2015 Sep; 30(9):1011-32. PubMed ID: 25896393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.
    Mallat A; Lotersztajn S
    Am J Physiol Cell Physiol; 2013 Oct; 305(8):C789-99. PubMed ID: 23903700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019.
    Dewidar B; Meyer C; Dooley S; Meindl-Beinker AN
    Cells; 2019 Nov; 8(11):. PubMed ID: 31718044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrogenesis: un update on established and emerging basic concepts.
    Novo E; Bocca C; Foglia B; Protopapa F; Maggiora M; Parola M; Cannito S
    Arch Biochem Biophys; 2020 Aug; 689():108445. PubMed ID: 32524998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and molecular mechanisms in liver fibrogenesis.
    Novo E; Cannito S; Paternostro C; Bocca C; Miglietta A; Parola M
    Arch Biochem Biophys; 2014 Apr; 548():20-37. PubMed ID: 24631571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA function in the profibrogenic interplay upon chronic liver disease.
    Huang J; Yu X; Fries JW; Zhang L; Odenthal M
    Int J Mol Sci; 2014 May; 15(6):9360-71. PubMed ID: 24871365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.
    Elpek GÖ
    World J Gastroenterol; 2014 Jun; 20(23):7260-76. PubMed ID: 24966597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.
    Ezhilarasan D; Sokal E; Najimi M
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):192-197. PubMed ID: 29709350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies.
    Parola M; Pinzani M
    Mol Aspects Med; 2024 Feb; 95():101231. PubMed ID: 38056058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C.
    Tanwar S; Rhodes F; Srivastava A; Trembling PM; Rosenberg WM
    World J Gastroenterol; 2020 Jan; 26(2):109-133. PubMed ID: 31969775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases.
    Cannito S; Paternostro C; Busletta C; Bocca C; Colombatto S; Miglietta A; Novo E; Parola M
    Histol Histopathol; 2014 Jan; 29(1):33-44. PubMed ID: 23996844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advancement of molecular mechanisms of liver fibrosis.
    Seki E; Brenner DA
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):512-8. PubMed ID: 25869468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver fibrosis: from the bench to clinical targets.
    Pinzani M; Rombouts K
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.
    Parola M; Marra F; Pinzani M
    Mol Aspects Med; 2008; 29(1-2):58-66. PubMed ID: 18022682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of Liver Fibrosis.
    Pinzani M
    Dig Dis; 2015; 33(4):492-7. PubMed ID: 26159264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver fibrosis: a dynamic and potentially reversible process.
    Povero D; Busletta C; Novo E; di Bonzo LV; Cannito S; Paternostro C; Parola M
    Histol Histopathol; 2010 Aug; 25(8):1075-91. PubMed ID: 20552556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis.
    Foglia B; Novo E; Protopapa F; Maggiora M; Bocca C; Cannito S; Parola M
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosis in the liver: acute protection and chronic disease.
    Lee Y; Friedman SL
    Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.